RMS Announces Results for Three, Ten and Twelve Months Ending December 31, 2017

  • Highest reported twelve month net sales and net income in RMS history
  • Double digit percentage growth in net sales
  • Increased profitability

CHESTER, NY / February 13, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced the latest financial results for the three, ten and twelve months ending December 31, 2017.

The selected financial results encompass the periods since the Company’s fiscal year ending on February 28, 2017.  To facilitate a period-to-period comparison despite the change in the Company’s fiscal year, the selected financial results also include the three and twelve-month periods ending December 31, 2017 and 2016.

Read Full Report